Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)

@article{Lanclus2017LateBA,
  title={Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)},
  author={Maarten Lanclus and Seth Porter and Benjamin Mignot and Elias Kouchakji and Eduard Gorina and Cedric Van Holsbeke and Jan De Backer and Wim Vos and Johan Clukers and Wilfried A. De Backer and Jonathan G. Goldin and Charles Mussche},
  journal={European Respiratory Journal},
  year={2017},
  volume={50}
}
Introduction: FRI can provide a detailed view of regional lung structure and function thereby capturing disease heterogeneity in IPF. Aims and objectives: To investigate the correlation between lung function and FRI parameters of lung and airway volumes. Methods: In this single arm study 66 IPF patients (67.9±7.0 years) completed 48 weeks of treatment with an anti-CTGF monoclonal antibody. Pulmonary function was assessed every 12 weeks and HRCT scans (TLC and RV) and were taken at baseline, 24w… Expand
2 Citations
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis
TLDR
The development and validation of six computer-based QCT methods are reviewed and insight is offered into the optimal use of an imaging-based biomarker as a tool for prognostication, prediction of response to therapy, and potential surrogate endpoint in future therapeutic trials. Expand
Using Quantitative Computed Tomographic Imaging to Understand Chronic Obstructive Pulmonary Disease and Fibrotic Interstitial Lung Disease
TLDR
The current state of the art for qualitative and qCT assessment of both COPD and fibrotic ILD are reviewed, along with the potential future role of artificial intelligence. Expand